Table 1. Castrate resistant prostate cancer treatment side effects.
Drug | Median OS (months) | S/E |
---|---|---|
Mitoxantrone | No improvement, but improved symptom palliation | Dyspnea, mucositis, cytopenias, cardiac dysfunction |
Docetaxel | 2.9 (mitoxantrone/prednisone) | Neutropenia, neuropathy, fatigue, N/V, alopecia, diarrhea, dyspnea, tearing, peripheral edema, nose bleeds |
Sipuleucel-T | 4.1 (placebo/prednisone) | Chills, HA, fever |
Abiraterone | 4.6 (post-docetaxel, placebo/prednisone) | Fatigue, arthralgia, peripheral edema, anemia, back pain, bone pain, hypokalemia |
Cabazitaxel | 2.4 (post-docetaxel, mitoxantrone/prednisone) | Neutropenia, diarrhea, N/V |
Enzalutamide | 4.8 (post-docetaxel, placebo/prednisone) | Fatigue, diarrhea, hot flashes, seizures |
Radium-223 dichloride | 2.8 (placebo) | Nausea, vomiting, peripheral edema |
OS, overall survival; S/E, side effects; N/V, nausea, vomiting; HA, headache.